Efficacy of Galantamine to Treat Schizophrenia

Clinical trial NCT00232349 · TERMINATED

Trial details

NCT number: NCT00232349
Sponsor: Seattle Institute for Biomedical and Clinical Research
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Psychotic Disorder

Start date: 2005-02-01
Primary completion: 2007-06-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.